Children diagnosed with diabetes during infancy have unique clinical characteristics

Revital Nimri1, Moshe Phillip, Shlomit Shalitin

  • 1Institute of Endocrinology and Diabetes, National Center of Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqwa, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Hormone Research
|December 16, 2006
PubMed

Insights

Early-onset diabetes in infants (6-24 months) presents unique clinical features, including more diabetic ketoacidosis and a higher celiac disease rate compared to older children. Understanding this distinct pattern is vital for effective diabetes management in young children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Autoimmune Diseases

Background:

  • Type 1 diabetes mellitus (T1DM) is increasingly diagnosed in young children.
  • Distinct clinical and biochemical profiles may exist for T1DM presenting in early infancy.
  • Early diagnosis and characterization are essential for optimal management and long-term outcomes.

Purpose of the Study:

  • To characterize the clinical and biochemical features of diabetes mellitus in children diagnosed between 6-24 months of age.
  • To compare these features with those of children diagnosed with diabetes at a later age (5-16 years).

Main Methods:

  • Retrospective review of medical records for 42 children diagnosed with diabetes between 6-24 months.
  • Comparison group of 60 children diagnosed with diabetes between 5-16 years.
  • Analysis of demographic, clinical, and biochemical data at diagnosis.

Main Results:

  • Infants diagnosed at 6-24 months exhibited more apathy, restlessness, and hyperglycemia during acute illness, with a lower remission rate.
  • Significantly higher rates of diabetic ketoacidosis (83% vs. 40%) and celiac disease (12% vs. 3%) were observed in the early-onset group.
  • Lower HbA1c levels (mean 11.6% vs. 13.75%) were noted in the younger group, with no significant differences in other autoimmune diseases.

Conclusions:

  • Diabetes presenting in infancy (6-24 months) may have a distinct clinical presentation and a higher prevalence of celiac disease.
  • Recognizing these differences is crucial for developing targeted interventional and preventive strategies for early-onset diabetes.
  • Further research into the specific pathophysiology and long-term course of diabetes in this age group is warranted.
Abstract

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...